In vitro physiological effects of Origanum onites L. (Lamiaceae) essential oil treatment on human origin cell lines

Origanum onites L. belongs to the Lamiaceae family which is commonly used for symptomatic treatment of the diseases of the gastrointestinal, endocrine, and respiratory systems in Turkish ethnobotanical studies and public. In this study our aim was to investigate the physiological effects of O. onites essential oil (OE) on A549 human lung cancer, MIA PaCa human pancreas cancer and HUVEC human endothelial cell lines. Our findings showed that O. onites OE treatment at all concentrations (4.79-191.6 mu g/mL, 24 h) can inhibit cell proliferation and induce apoptosis in A549 and MIA PaCa cell lines (P = 38.32 mu g/mL) significantly inhibited cell proliferation. Apoptotic cell counts were significantly (P

Keywords:

Origanum onites, cellular-migration, apoptosis, proliferation cancer, wound healing,

PDF

___

Abdel-Massih RM, 2010, LEUKEMIA RES, V34, P1052, DOI 10.1016/j.leukres.2009.09.018
Al Dhaheri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068808
Al Kahlout A, 2014, QAT FDN ANN RES C QA, DOI [10.5339/ qfarc.2014.HBSP1103, DOI 10.5339/QFARC.2014.HBSP1103]
Al-Kalaldeh JZ, 2010, NUTR RES, V30, P271, DOI 10.1016/j.nutres.2010.04.001
Aldisi S. S., 2019, Journal of Herbs, Spices & Medicinal Plants, V25, P202, DOI 10.1080/10496475.2019.1587674
Aridogan BC, 2002, ARCH PHARM RES, V25, P860, DOI 10.1007/BF02977005
Baranauskaite J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1681392
Bostancioglu RB, 2012, FOOD CHEM TOXICOL, V50, P2002, DOI 10.1016/j.fct.2012.03.074
Bulut G, 2013, J ETHNOPHARMACOL, V149, P633, DOI 10.1016/j.jep.2013.07.016
Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011
Dai W, 2016, ONCOTARGETS THER, V9, P2297, DOI 10.2147/OTT.S98875
Fan K, 2015, ANTI-CANCER DRUG, V26, P813, DOI 10.1097/CAD.0000000000000263
Fitsiou E, 2016, MOLECULES, V21, DOI 10.3390/molecules21081069
Hazzit M, 2006, J AGR FOOD CHEM, V54, P6314, DOI 10.1021/jf0606104
Ietswaart JH, 1982, FLORA TURKEY E AEGEA, V7, P308
Jaafari A, 2012, REV BRAS FARMACOGN, V22, P534, DOI 10.1590/S0102-695X2012005000021
Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180
Jssim Abdul-Halim AG, 2020, PLANT ARCH, V20, P817
Jung CY, 2018, ANTICANCER RES, V38, P279, DOI 10.21873/anticanres.12219
Khan I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18644-9
Larsen KE, 2002, J NEUROSCI, V22, P8951 .
Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
Liu K, 2015, MED SCI MONIT BASIC, V21, P15, DOI 10.12659/MSMBR.893327
Llana-Ruiz-Cabello M, 2017, FOOD CHEM TOXICOL, V101, P36, DOI 10.1016/j.fct.2017.01.001
Novato TPL, 2015, VET PARASITOL, V212, P331, DOI 10.1016/j.vetpar.2015.08.021
Loziene K, 2005, BIOCHEM SYST ECOL, V33, P517, DOI 10.1016/j.bse.2004.10.004
Matluobi D, 2018, MICROVASC RES, V115, P20, DOI 10.1016/j.mvr.2017.08.003
Misharina TA, 2013, APPL BIOCHEM MICRO+, V49, P432, DOI 10.1134/S0003683813040091
MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
Ozkan A, 2011, TURK J BIOL, V35, P735, DOI 10.3906/biy-1011-170
Rojas-Armas JP, 2020, MOLECULES, V25, DOI 10.3390/molecules25143284
Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004
Polat R, 2012, J ETHNOPHARMACOL, V139, P626, DOI 10.1016/j.jep.2011.12.004
Rajput JD, 2017, RES CHEM INTERMEDIAT, V43, P6601, DOI 10.1007/s11164-017-3007-3
Sagiroglu M., 2013, Journal of Medicinal Plants Research, V7, P2053
Sargin SA, 2013, J ETHNOPHARMACOL, V150, P860, DOI 10.1016/j.jep.2013.09.040
Sari I, 2020, ANKARA U ECZACILIK F, V44, P281, DOI [10.33483/jfpau.707277, DOI 10.33483/JFPAU.707277]
Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
Sivas H, 2011, ANADOLU UNIVERSITESI, V1, P171
Spyridopoulou K, 2019, MOLECULES, V24, DOI 10.3390/molecules24142612
Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
Trindade GGG, 2019, FOOD CHEM TOXICOL, V125, P198, DOI 10.1016/j.fct.2019.01.003
VOKOU D, 1988, ECON BOT, V42, P407, DOI 10.1007/BF02860163